Cytokinetics Eulerpool naujienos

Cytokinetics akcijų naujienos

Cytokinetics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Cytokinetics naujienas mes pateikiame čia.

• gruodžio 23 d. ·

  Yahoo
  Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
• gruodžio 20 d. ·

  Yahoo
  Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
• gruodžio 19 d. ·

  Yahoo
  Calculating The Fair Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)
• gruodžio 6 d. ·

  Yahoo
  Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?
• gruodžio 3 d. ·

  Yahoo
  Sector Update: Health Care Stocks Mixed Late Afternoon
• gruodžio 3 d. ·

  Yahoo
  Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction
• gruodžio 2 d. ·

  Yahoo
  Cytokinetics to Participate in December Investor Conferences
• gruodžio 2 d. ·

  Yahoo
  Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
• gruodžio 2 d. ·

  Yahoo
  Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date
• lapkričio 22 d. ·

  Yahoo
  Cytokinetics price target raised to $103 from $99 at Mizuho